Carmel, IN, United States of America

Masahiro Murakami

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Murakami. Retrieved from https://idiyas.com/inventor/masahiro-murakami-lskoxxbr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Murakami: Innovator in Therapeutic Applications

Introduction

Masahiro Murakami is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of therapeutics, particularly through his work at Eli Lilly and Company. His innovative approach has led to the development of valuable medical applications.

Latest Patents

Murakami holds a patent titled "Therapeutic Uses of Tirzepatide." This patent represents his commitment to advancing medical science and improving patient outcomes. With 1 patent to his name, he continues to be a key player in the pharmaceutical industry.

Career Highlights

Throughout his career, Murakami has demonstrated a strong dedication to research and development. His work at Eli Lilly and Company has positioned him as a leader in therapeutic innovations. His contributions have not only advanced the company's goals but have also had a positive impact on healthcare.

Collaborations

Murakami has collaborated with talented individuals such as Axel Haupt and Jeffrey Scott Riesmeyer. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Masahiro Murakami's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to therapeutic applications highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…